Gene: TMEM225B
Official Full Name: transmembrane protein 225Bprovided by HGNC
Gene Summary: Predicted to be located in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO13202 | TMEM225B Knockout cell line (HCT 116) | Human | TMEM225B | 1:2~1:4 | Negative | Online Inquiry |
KO13203 | TMEM225B Knockout cell line (A549) | Human | TMEM225B | 1:3~1:4 | Negative | Online Inquiry |
TMEM225B Gene Knockout Cell Lines are sophisticated cellular models engineered to facilitate the study of the TMEM225B gene's role in various biological processes. TMEM225B, a member of the transmembrane protein family, is implicated in multiple cellular functions including signal transduction and cellular metabolism. By effectively knocking out this gene, these cell lines provide researchers with a unique opportunity to observe the cellular and molecular consequences of its absence, thereby elucidating the gene's function in health and disease contexts.
These knockout cell lines utilize CRISPR/Cas9 technology to induce precise deletions within the TMEM225B gene, resulting in the abolition of its expression. This advanced genetic manipulation allows for the study of subsequent phenotypic changes, aiding in the exploration of pathways affected by TMEM225B dysfunction. They have significant applications in both basic research and translational studies, especially in understanding diseases related to cellular signaling anomalies, such as cancer and metabolic disorders.
Compared to traditional knockout models, TMEM225B Gene Knockout Cell Lines offer superior specificity and efficiency, coupled with the capability for rapid generation and validation. This ensures that researchers can obtain reliable data faster, ultimately accelerating the pace of scientific discovery. As an added advantage, our products are rigorously validated for consistency and performance, providing confidence in experimental reproducibility.
The value of TMEM225B Gene Knockout Cell Lines extends beyond academic research; they are also vital for pharmaceutical development and personalized medicine approaches, allowing for drug testing in genetically relevant cellular contexts.
Our company boasts extensive expertise in cellular engineering and gene editing technologies, offering a portfolio of high-quality biological products that empower researchers and clinicians alike. With a commitment to scientific advancement, we strive to provide innovative solutions tailored specifically to the needs of the scientific community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.